At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,025 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post Market Observational Study to Obtain Additional Information on the Use of Cormatrix® Cangaroo ECM® Envelope
In Brief
An observational study for Cardiovascular Disease. Completed, enrolled 1,025 participants across 39 sites.
Detailed Summary
The objective of the SECURE Study is to actively gather additional information on the use of the CorMatrix® CanGaroo ECM® Envelope in a post market observational study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 2015
Enrollment StartOct 2015
Primary CompletionDec 2017
Study CompletionApr 2018
TodayJul 2026
First PostedAug 21, 2015
Enrollment StartOct 1, 2015
Primary CompletionDec 1, 2017
Study CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 10.9 years ago